RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies

  • sponsor
    The Rogosin Institute
Updated on 25 March 2021


RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies


The purpose of this research bio-repository study is to collect demographic, clinical, biochemical, histological, and genetic (RNA) data and samples from a large population of subjects with a variety of renal disease states, including diabetic, inflammatory, autoimmune and transplant related renal conditions, in order to assess for factors that may be associated with the progression of disease, the incidence of complications, (including renal failure), and the responses to therapy. In addition, the bio-repository will include the collection of data and samples from control subjects without established renal disease.

This study will provide an opportunity to compare data from various disease states with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating non-invasive clinical and biological features that predict renal biopsy findings.

Potential Benefits: There is no guarantee that subjects will benefit personally from this study. Knowledge gained from RENAL AID may benefit subjects and others in the future.

For More Information Contact:

Nelson Chen, MA, Clinical Research Coordinator

Condition Kidney Disease
Clinical Study IdentifierTX150221
SponsorThe Rogosin Institute
Last Modified on25 March 2021


Yes No Not Sure

Inclusion Criteria

Key eligibility: Males or females, at least 18 years of age and if you
Require an initial kidney biopsy for medical necessity; or
Previously had a kidney biopsy and the tissue is not stored in this biorepository; or?
Have diabetes and kidney disease and have not had a kidney biopsy; or
Had a kidney transplant and require a transplant biopsy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note